VR Logo

Strides Pharma Science Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1990

Chairman: Deepak Vaidya

Managing Director: --

Group: --

Listing: NSE: STAR, BSE: 532531

Headquarters: Navi Mumbai, Maharashtra

Website: www.stridesarco.com

Key Facts

Market cap: R 2,753.24 Cr

Revenue (TTM): R 2,973.03 Cr

Earnings (TTM): R 365.45 Cr

Cash: R 801.40 Cr

Total Debt: R 3,221.47 Cr

Promoters' ownership: 31.28%

Liquidity: High

52 Week range: R 268.00 - 547.65

Face value: R10.00

Shares outstanding: 8,95,65,464

Stock Performance

Time Period Strides Pharma Science S&P BSE Small Cap S&P BSE Healthcare
YTD-15.20-31.32-7.70
1 month-34.11-31.69-10.97
3 months-19.02-32.74-8.74
1 Year-35.31-37.21-12.90
3 Years-35.19-13.65-7.12
5 Years-23.80-3.33-6.85
10 Years-0.940.788.77
As on 03-Apr-2020
Year Strides Pharma Science S&P BSE Small Cap S&P BSE Healthcare
2019-22.35-6.85-3.55
2018-43.80-23.41-5.89
2017-22.5259.640.49
2016-18.621.77-12.88
201534.176.7615.06
2014165.4169.2447.43
2013-66.90-11.2322.55

Review & Analysis